NASDAQ:STAA

STAAR Surgical - STAA Stock Forecast, Price & News

$87.72

+3.21 (+3.80%)

(As of 08/8/2022 12:00 AM ET)

Add

Compare

Today's Range: $84.72
▼
$90.12
50-Day Range: $62.10
▼
$87.72
52-Week Range: $49.03
▼
$163.08

Volume: 429,452 shs
Average Volume: 471,590 shs
Market Capitalization: $4.19 billion

P/E Ratio: 151.24
Dividend Yield: N/A
Price Target: $92.00

STAAR Surgical MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 4.9% Upside
$92.00 Price Target
Short Interest: Healthy
6.13% of Shares Sold Short
Dividend Strength: N/A
Sustainability: -0.73
Upright™ Environmental Score
News Sentiment: 0.78
Based on 2 Articles This Week
Insider Trading: Selling Shares
$2.01 M Sold Last Quarter
Proj. Earnings Growth: 72.31%
From $0.65 to $1.12 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.15 out of 5 stars

Medical Sector

513th out of 1,293 stocks

Ophthalmic Goods Industry

6th out of 7 stocks

1.5

Analyst's Opinion

Consensus Rating
STAAR Surgical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $92.00, STAAR Surgical has a forecasted upside of 4.9% from its current price of $87.72.
Amount of Analyst Coverage
STAAR Surgical has received no research coverage in the past 90 days.

4.0

Short Interest

Percentage of Shares Shorted
6.13% of the outstanding shares of STAAR Surgical have been sold short.
Short Interest Ratio / Days to Cover
STAAR Surgical has a short interest ratio ("days to cover") of 5.7.
Change versus previous month
Short interest in STAAR Surgical has recently decreased by 7.28%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
STAAR Surgical does not currently pay a dividend.
Dividend Growth
STAAR Surgical does not have a long track record of dividend growth.

4.1

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
STAAR Surgical has received a 58.64% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Intraocular lenses" product. See details.
Environmental Sustainability
The Environmental Impact score for STAAR Surgical is -0.73.

2.7

News and Social Media Coverage

News Sentiment
STAAR Surgical has a news sentiment score of 0.78. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.32 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for STAAR Surgical this week, compared to 2 articles on an average week.
Search Interest
Only 4 people have searched for STAA on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
MarketBeat Follows
5 people have added STAAR Surgical to their MarketBeat watchlist in the last 30 days. This is an increase of 150% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, STAAR Surgical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,012,150.00 in company stock.
Percentage Held by Insiders
Only 2.60% of the stock of STAAR Surgical is held by insiders.
Percentage Held by Institutions
89.93% of the stock of STAAR Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for STAAR Surgical are expected to grow by 72.31% in the coming year, from $0.65 to $1.12 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of STAAR Surgical is 151.24, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 136.31.
Price to Earnings Ratio vs. Sector
The P/E ratio of STAAR Surgical is 151.24, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 120.32.
Price to Book Value per Share Ratio
STAAR Surgical has a P/B Ratio of 16.15. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About STAAR Surgical (NASDAQ:STAA) Stock

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

STAAR Surgical Price Performance

STAA opened at $87.72 on Tuesday. The firm has a fifty day moving average price of $73.35 and a 200 day moving average price of $70.00. STAAR Surgical has a 1 year low of $49.03 and a 1 year high of $163.08. The stock has a market cap of $4.19 billion, a P/E ratio of 151.24 and a beta of 1.09.

Analysts Set New Price Targets

STAA has been the topic of a number of research reports. Canaccord Genuity Group raised their target price on shares of STAAR Surgical from $81.00 to $89.00 and gave the company a "buy" rating in a research report on Tuesday, April 26th. Canaccord Genuity Group lifted their price objective on shares of STAAR Surgical from $81.00 to $89.00 and gave the stock a "buy" rating in a research report on Tuesday, April 26th. BTIG Research reaffirmed a "buy" rating and issued a $98.00 price objective on shares of STAAR Surgical in a research report on Saturday, April 23rd. Finally, Needham & Company LLC reaffirmed a "buy" rating and issued a $87.00 price objective on shares of STAAR Surgical in a research report on Tuesday, May 3rd. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $92.00.

Insider Buying and Selling

In other news, CEO Caren L. Mason sold 35,000 shares of the company's stock in a transaction on Thursday, May 19th. The shares were sold at an average price of $57.49, for a total transaction of $2,012,150.00. Following the completion of the sale, the chief executive officer now owns 83,645 shares of the company's stock, valued at $4,808,751.05. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 2.60% of the stock is owned by insiders.

Receive STAA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter.

STAA Stock News Headlines

August 3, 2022 | finance.yahoo.com

If EPS Growth Is Important To You, STAAR Surgical (NASDAQ:STAA) Presents An Opportunity

July 30, 2022 | nasdaq.com

For STAAR Surgical Company (NASDAQ:STAA) insiders, selling US$5.4m worth of stock earlier this year was a smart move.

July 27, 2022 | thestreet.com

STAAR Surgical Company News

July 26, 2022 | americanbankingnews.com

STAAR Surgical (NASDAQ:STAA) Given Consensus Recommendation of "Moderate Buy" by Analysts

July 20, 2022 | finance.yahoo.com

STAAR Surgical to Report Second Quarter Results on August 10, 2022

July 6, 2022 | finance.yahoo.com

STAAR Surgical Company's (NASDAQ:STAA) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

July 5, 2022 | seekingalpha.com

STAAR Surgical: Hard Data Approach Justifies Long-Only Portfolio Allocation

June 27, 2022 | finance.yahoo.com

Wall Street Analysts See a 42% Upside in Staar Surgical (STAA): Can the Stock Really Move This High?

June 27, 2022 | finance.yahoo.com

Here is Why Growth Investors Should Buy Staar Surgical (STAA) Now

June 17, 2022 | finance.yahoo.com

Should You Buy Stocks When the Market Crashes?

June 9, 2022 | finance.yahoo.com

3 Reasons Why Growth Investors Shouldn't Overlook Staar Surgical (STAA)

June 9, 2022 | finance.yahoo.com

Wall Street Analysts See a 47% Upside in Staar Surgical (STAA): Can the Stock Really Move This High?

June 7, 2022 | finance.yahoo.com

STAAR Surgical Celebrates Two Million Lens Milestone for Implantable Collamer® Lens (ICL)

June 6, 2022 | finance.yahoo.com

Is There Now An Opportunity In STAAR Surgical Company (NASDAQ:STAA)?

May 24, 2022 | finance.yahoo.com

Wall Street Analysts Think Staar Surgical (STAA) Could Surge 76%: Read This Before Placing a Bet

May 22, 2022 | finance.yahoo.com

Those who invested in STAAR Surgical (NASDAQ:STAA) five years ago are up 538%

May 17, 2022 | finance.yahoo.com

3 Reasons Growth Investors Will Love Staar Surgical (STAA)

May 7, 2022 | finance.yahoo.com

Earnings Beat: STAAR Surgical Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

May 4, 2022 | seekingalpha.com

STAAR Surgical Company's (STAA) CEO Caren Mason On Q1 2022 Results - Earnings Call Transcript

May 4, 2022 | ca.investing.com

STAAR Surgical Tops Q1 EPS by 11c

May 4, 2022 | nasdaq.com

STAAR Surgical Company Q1 Profit Increases, beats estimates

May 4, 2022 | finance.yahoo.com

STAAR Surgical Reports Record First Quarter Net Sales of $63.2 Million Up 25% Y/Y

May 4, 2022 | nasdaq.com

After Falling More Than 56% in a Year, Is STAAR Surgical Doomed?

May 3, 2022 | seekingalpha.com

STAAR Surgical Q1 2022 Earnings Preview

May 3, 2022 | markets.businessinsider.com

STAAR Surgical Company earnings preview: what Wall Street is expecting

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive STAA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter.

STAA Company Calendar

Last Earnings: 11/03/2021
Today: 8/09/2022
Next Earnings (Confirmed): 8/10/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Ophthalmic goods
Sub-Industry: Health Care Supplies
Sector: Medical
Current Symbol: NASDAQ:STAA
CUSIP: 85231230
CIK: 718937
Web: www.staar.com
Phone: (626) 303-7902
Fax: 626-303-2962
Employees: 692
Year Founded: 1982

Price Target and Rating

Average Stock Price Forecast: $92.00
High Stock Price Forecast: $98.00
Low Stock Price Forecast: $87.00
Forecasted Upside/Downside: +4.9%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 5 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.58
Trailing P/E Ratio: 151.24
Forward P/E Ratio: 134.95
P/E Growth: N/A
Net Income: $24.50 million
Net Margins: 11.98%
Pretax Margin: 15.06%
Return on Equity: 12.78%
Return on Assets: 9.89%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 6.65
Quick Ratio: 6.20

Sales & Book Value

Annual Sales: $230.47 million
Price / Sales: 18.20
Cash Flow: $0.70 per share
Price / Cash Flow: 125.90
Book Value: $5.43 per share
Price / Book: 16.15

Miscellaneous

Outstanding Shares: 47,811,000
Free Float: 46,568,000
Market Cap: $4.19 billion
Optionable: Optionable
Beta: 1.09

Social Links

Key Executives

Ms. Caren L. Mason (Age 68)
CEO, Pres & Director
Comp: $1.97M
Mr. Patrick F. Williams (Age 49)
Chief Financial Officer
Comp: $934.82k
Dr. Keith Holliday (Age 59)
Chief Technology Officer
Comp: $822.97k
Mr. Hans-Martin Blickensdoerfer (Age 57)
Sr. VP of Commercial Operations and Director of Markets - Europe & China
Comp: $756.58k
Dr. Scott D. Barnes M.D. (Age 59)
Chief Medical Officer
Comp: $874.46k
Mr. Brian Moore
VP of Investor, Media Relations & Corp. Devel.
Mr. Samuel J. Gesten (Age 60)
Chief Legal Officer & Corp. Sec.
Mr. James Francese (Age 58)
Sr. VP of Commercial Operations - North America & APAC
Joanne Egamino Ph.D.
Global Head of Clinical Operations
Mr. Philippe Subrin (Age 58)
VP of Collamer Lens Manufacturing & GM of Nidau Operations

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

STAA Stock - Frequently Asked Questions

Should I buy or sell STAAR Surgical stock right now?: 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" STAA shares.
View STAA analyst ratings or view top-rated stocks.
What is STAAR Surgical's stock price forecast for 2022?: 5 brokers have issued 1 year price objectives for STAAR Surgical's shares. Their STAA share price forecasts range from $87.00 to $98.00. On average, they predict the company's share price to reach $92.00 in the next twelve months. This suggests a possible upside of 4.9% from the stock's current price.
View analysts price targets for STAA or view top-rated stocks among Wall Street analysts.
How has STAAR Surgical's stock price performed in 2022?: STAAR Surgical's stock was trading at $91.30 at the beginning of 2022. Since then, STAA shares have decreased by 3.9% and is now trading at $87.72.
View the best growth stocks for 2022 here.
When is STAAR Surgical's next earnings date?: STAAR Surgical is scheduled to release its next quarterly earnings announcement on Wednesday, August 10th 2022.
View our STAA earnings forecast.
How can I listen to STAAR Surgical's earnings call?: STAAR Surgical will be holding an earnings conference call on Wednesday, August 10th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 929-458-6194 with passcode "944172".
How were STAAR Surgical's earnings last quarter?: STAAR Surgical (NASDAQ:STAA) posted its earnings results on Wednesday, November, 3rd. The medical instruments supplier reported $0.12 EPS for the quarter, topping the consensus estimate of $0.11 by $0.01. The medical instruments supplier had revenue of $58.35 million for the quarter, compared to the consensus estimate of $57.70 million. STAAR Surgical had a trailing twelve-month return on equity of 12.78% and a net margin of 11.98%. During the same quarter last year, the business earned $0.14 EPS.
What guidance has STAAR Surgical issued on next quarter's earnings?: STAAR Surgical issued an update on its FY 2022 earnings guidance on Monday, May, 16th. The company provided EPS guidance of for the period. The company issued revenue guidance of $295.00 million-$295.00 million, compared to the consensus revenue estimate of $295.37 million.
What is Caren Mason's approval rating as STAAR Surgical's CEO?: 6 employees have rated STAAR Surgical Chief Executive Officer Caren Mason on Glassdoor.com. Caren Mason has an approval rating of 68% among the company's employees.

What other stocks do shareholders of STAAR Surgical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other STAAR Surgical investors own include Tesla (TSLA), NVIDIA (NVDA), PayPal (PYPL), Walt Disney (DIS), CrowdStrike (CRWD), DocuSign (DOCU), Shopify (SHOP), Trade Desk (TTD), Teladoc Health (TDOC) and Roku (ROKU).
What is STAAR Surgical's stock symbol?: STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."
Who are STAAR Surgical's major shareholders?: STAAR Surgical's stock is owned by many different institutional and retail investors. Top institutional shareholders include Baillie Gifford & Co. (11.05%), Geneva Capital Management LLC (1.90%), Defender Capital LLC. (0.90%), TimesSquare Capital Management LLC (0.84%), Loomis Sayles & Co. L P (0.72%) and Kornitzer Capital Management Inc. KS (0.45%). Insiders that own company stock include Broadwood Partners, LP, Caren L Mason, Deborah J Andrews, Graydon C Hansen, Graydon C Hansen, Hans-Martin Blickensdoerfer, James E Francese, Jon K Hayashida, Keith Holliday, Patrick F Williams, Samuel J Gesten and Scott D Barnes.
View institutional ownership trends.
How do I buy shares of STAAR Surgical?: Shares of STAA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is STAAR Surgical's stock price today?: One share of STAA stock can currently be purchased for approximately $87.72.
How much money does STAAR Surgical make?: STAAR Surgical (NASDAQ:STAA) has a market capitalization of $4.19 billion and generates $230.47 million in revenue each year. The medical instruments supplier earns $24.50 million in net income (profit) each year or $0.58 on an earnings per share basis.
How many employees does STAAR Surgical have?: STAAR Surgical employs 692 workers across the globe.
Does STAAR Surgical have any subsidiaries?: The following companies are subsidiares of STAAR Surgical: Canon Staar, Frigitronics Inc., STAAR Japan Inc., STAAR Optical Equipment, STAAR Surgical AG, STAAR Surgical PTE. LTD, and Technology (Shanghai) Co. LTD.
Read More
When was STAAR Surgical founded?: STAAR Surgical was founded in 1982.
How can I contact STAAR Surgical?: STAAR Surgical's mailing address is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. The official website for the company is www.staar.com. The medical instruments supplier can be reached via phone at (626) 303-7902, via email at bmoore@staar.com, or via fax at 626-303-2962.

This page (NASDAQ:STAA) was last updated on 8/9/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

STAAR Surgical - STAA Stock Forecast, Price & News

STAAR Surgical MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About STAAR Surgical (NASDAQ:STAA) Stock

STAAR Surgical Price Performance

Analysts Set New Price Targets

Insider Buying and Selling

STAA Stock News Headlines

STAA Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

STAA Stock - Frequently Asked Questions

Should I buy or sell STAAR Surgical stock right now?

What is STAAR Surgical's stock price forecast for 2022?

How has STAAR Surgical's stock price performed in 2022?

When is STAAR Surgical's next earnings date?

How can I listen to STAAR Surgical's earnings call?

How were STAAR Surgical's earnings last quarter?

What guidance has STAAR Surgical issued on next quarter's earnings?

What is Caren Mason's approval rating as STAAR Surgical's CEO?

What other stocks do shareholders of STAAR Surgical own?

What is STAAR Surgical's stock symbol?

Who are STAAR Surgical's major shareholders?

How do I buy shares of STAAR Surgical?

What is STAAR Surgical's stock price today?

How much money does STAAR Surgical make?

How many employees does STAAR Surgical have?

Does STAAR Surgical have any subsidiaries?

When was STAAR Surgical founded?

How can I contact STAAR Surgical?

MarketBeat Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources

Overall MarketRank^™